<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T10:11:01Z</responseDate>
  <request identifier="oai:figshare.com:article/33956112" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33956112</identifier>
        <datestamp>2026-09-21T17:28:21Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Impacts on medication prescriptions of one or more multi-professional medication reviews (MPMR), n = 120.&lt;/p&gt;</dc:title>
          <dc:creator>Matthieu Lebrat (18400644)</dc:creator>
          <dc:creator>Ahava Cohen (25084524)</dc:creator>
          <dc:creator>Rachel Megard (18400647)</dc:creator>
          <dc:creator>Nicolas Franck (169512)</dc:creator>
          <dc:creator>Claude Dussart (5843525)</dc:creator>
          <dc:creator>Marion Perin-Dureau (25084527)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>specific drug classes</dc:subject>
          <dc:subject>mixed linear models</dc:subject>
          <dc:subject>four psychiatric wards</dc:subject>
          <dc:subject>electronic medical records</dc:subject>
          <dc:subject>collaborative processes designed</dc:subject>
          <dc:subject>professional medication reviews</dc:subject>
          <dc:subject>overall psychotropic deprescribing</dc:subject>
          <dc:subject>optimize medication management</dc:subject>
          <dc:subject>two hospital stays</dc:subject>
          <dc:subject>potentially inappropriate medications</dc:subject>
          <dc:subject>french university hospital</dc:subject>
          <dc:subject>december 2023 ).</dc:subject>
          <dc:subject>laxatives (− 0</dc:subject>
          <dc:subject>mlm ), adjusting</dc:subject>
          <dc:subject>xlink "&gt; multi</dc:subject>
          <dc:subject>xlink "&gt; mpmrs</dc:subject>
          <dc:subject>psychiatry &lt;/ p</dc:subject>
          <dc:subject>p ≤ 0</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>overall reduction</dc:subject>
          <dc:subject>medication prescriptions</dc:subject>
          <dc:subject>medication appropriateness</dc:subject>
          <dc:subject>05 ),</dc:subject>
          <dc:subject>total medications</dc:subject>
          <dc:subject>prescribed medications</dc:subject>
          <dc:subject>18 ).</dc:subject>
          <dc:subject>05 ).</dc:subject>
          <dc:subject>targeted decreases</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>significant reduction</dc:subject>
          <dc:subject>significant decreases</dc:subject>
          <dc:subject>significant changes</dc:subject>
          <dc:subject>retrospectively assess</dc:subject>
          <dc:subject>reducing high</dc:subject>
          <dc:subject>randomized designs</dc:subject>
          <dc:subject>promote evidence</dc:subject>
          <dc:subject>primary outcome</dc:subject>
          <dc:subject>patient safety</dc:subject>
          <dc:subject>mpmr implementation</dc:subject>
          <dc:subject>mood stabilizers</dc:subject>
          <dc:subject>hospitalization duration</dc:subject>
          <dc:subject>explore long</dc:subject>
          <dc:subject>cohen ’</dc:subject>
          <dc:subject>based practice</dc:subject>
          <dc:subject>1 drugs</dc:subject>
          <dc:description>&lt;p&gt;Impacts on medication prescriptions of one or more multi-professional medication reviews (MPMR), n = 120.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T17:28:13Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358539.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Impacts_on_medication_prescriptions_of_one_or_more_multi-professional_medication_reviews_MPMR_n_120_p_/33956112</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
